Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitelliform macular dystrophy.

Richard F Spaide1, Kenneth Noble, Alexander Morgan

  • 1Vitreous, Retina, Macula Consultants of New York and the LuEsther T. Mertz Retina Research Laboratory, Manhattan Eye, Ear, and Throat Hospital, New York, New York 10022, USA. rickspaide@yahoo.com

Ophthalmology
|August 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comparison of Approaches for Motion Artifact Removal from Wireless Mobile EEG During Overground Running.

Sensors (Basel, Switzerland)·2025
Same author

Tailoring of Self-Healable Polydimethylsiloxane Films for Mechanical Energy Harvesting.

ACS applied energy materials·2024
Same author

Comparison of Impact Accelerations During Performance of Common Ballet Maneuvers: A Pilot Study.

Journal of dance medicine & science : official publication of the International Association for Dance Medicine & Science·2023
Same author

Intrapulmonary shunting is a key contributor to hypoxia in COVID-19: An update on the pathophysiology.

PloS one·2022
Same author

ARE THERE TWO FORMS OF MULTIPLE EVANESCENT WHITE DOT SYNDROME?

Retina (Philadelphia, Pa.)·2021
Same author

Vortex Vein Imaging: What Can It Tell Us?

Clinical ophthalmology (Auckland, N.Z.)·2021
Same journal

Value of 10-2 Visual Field Testing for Detecting Progression in Patients with Glaucoma.

Ophthalmology·2026
Same journal

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis.

Ophthalmology·2026
Same journal

Diverse Conjunctival Adverse Events Associated with Tisotumab Vedotin.

Ophthalmology·2026
Same journal

The Answer Is Blowing in the Wind: Uncovering Hidden Glaucoma Risk Factors.

Ophthalmology·2026
Same journal

Nonsteroidal Anti-inflammatory Drug Use Reduces the Risk of Age-Related Macular Degeneration in Electronic Health Record Analysis: Signal or Solution?

Ophthalmology·2026
Same journal

Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

Ophthalmology·2026
See all related articles

Vitelliform macular dystrophy type 2 (VMD2), or Best's disease, involves yellowish material accumulation and subretinal fluid. This imaging study suggests shed photoreceptor outer segments contribute to VMD2 pathogenesis, similar to chronic central serous chorioretinopathy.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Genetics

Background:

  • Vitelliform macular dystrophy type 2 (VMD2), also known as Best's disease, is a hereditary macular disorder.
  • Understanding its pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To integrate multimodal imaging findings in VMD2 patients.
  • To propose pathogenic mechanisms for VMD2 based on integrated imaging data.

Main Methods:

  • Retrospective observational case series of nine VMD2 patients.
  • Utilized fundus photography, autofluorescence, fluorescein angiography, and optical coherence tomography (OCT).

Main Results:

  • Early VMD2 lesions showed autofluorescent material on the outer retina (OCT).

Related Experiment Videos

  • Later stages featured central clearing and peripheral subretinal autofluorescent material with subretinal fluid.
  • Fluorescein angiography revealed transmission defects and late leakage, resembling chronic central serous chorioretinopathy (CSC).

    • Conclusions:

    • VMD2 involves accumulation of material on the outer retina, potentially shed photoreceptor outer segments.
    • Subretinal fluid is a consistent finding in both early and late stages of VMD2.
    • Pathogenesis may share similarities with chronic central serous chorioretinopathy.